Epigenetics
The Biocius (
www.biocius.com) RapidFire label- free mass spectrometry platform enables high throughput analysis of a wide range of epigenetic target enzymes. The system is uniquely capable of detecting multiple modification events across a sin- gle, native substrate; a challenging endeavour with other technologies using optically or radioactively labelled surrogate substrates. For example, lysine can accommodate up to three methyl groups, thus a variety of methylated states are possible depend- ing on the activity of methylases and demethylases acting upon the protein. RapidFire mass spectrom- etry can detect and distinguish any of the methyla- tion patterns: unmethylated, single, di- or tri- methylated. The RapidFire platform has been used to assess the activity of a variety of epigenetic enzymes, including protein acetylases/deacetylases, protein methylases/demethylases and DNA methy- lases/demethylases. Recent RapidFire data even demonstrates the simultaneous monitoring of SIRT-1 mediated deacetylation at several sites in the p53 gene sequence. Additionally, RapidFire technology demonstrates much faster analysis
Figure 11: Sequential deacetylation of a triply-acetylated p53 peptide by SIRT1 using Biocius RapidFire
Address Even the Most Di cult Assays RapidFireTM enables label-free
detec on of na ve analytes for previously intractable targets
Label-free screening for:
• oncology • epigene cs • metabolic disorders • cardiovascular disease • an -infec ves • neurological disorders • infl amma on
T: 781.928.2700 | F: 781.998.0054 |
www.BIOCIUS.com |
info@BIOCIUS.com Drug Discovery World Spring 2011 45
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80